Home Business Wall Street Review: Stocks Set Multiple Records Ahead of Fed Meeting

Wall Street Review: Stocks Set Multiple Records Ahead of Fed Meeting

Share
wall-street-review:-stocks-set-multiple-records-ahead-of-fed-meeting
Wall Street Review: Stocks Set Multiple Records Ahead of Fed Meeting
Share

The continued weakening of the labor market further boosted the probability of an interest rate cut.

Wall Street Review: Stocks Set Multiple Records Ahead of Fed Meeting

Traders work on the floor of the New York Stock Exchange during morning trading on Sept. 12, 2025. Michael M. Santiago/Getty Images

Panos Mourdoukoutas

|Updated:

News Analysis

Stocks hit multiple records this week, lifted by robust revenue guidance from tech giant Oracle, steady bond yields, and a flurry of IPOs that eased concerns over market valuation.

Panos Mourdoukoutas

Panos Mourdoukoutas

Author

Panos Mourdoukoutas is a professor of economics at Long Island University in New York City. He also teaches security analysis at Columbia University. He’s been published in professional journals and magazines, including Forbes, Investopedia, Barron’s, IBT, and Journal of Financial Research. He’s also the author of many books, including “Business Strategy in a Semiglobal Economy” and “China’s Challenge.”

Author’s Selected Articles

Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...